Product

XTMAB-16

Aliases

XTMAB-16 or Placebo

2 clinical trials

1 indication

Indication

Clinical trial

A Seamless, Phase 1b/2 Multiple Ascending Dose/Proof of Concept Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

Status: Recruiting, Estimated PCD: 2026-04-01

Clinical trial

A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement

Status: , Estimated PCD: 2029-01-01